Future Fintech (FTFT) had the highest return between 2005 and 2009 by a US stock, returning 599,272,627.3%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Future Fintech (FTFT) | 2005-2009 | 599,272,627.27% |
Cemtrex (CETX) | 2005-2009 | 22,635,714.89% |
INVO Fertility (IVF) | 2005-2009 | 10,367,900% |
Ridgetech (RDGT) | 2005-2009 | 6,872,627.27% |
Archrock (AROC) | 2005-2009 | 5,798,150% |
Seanergy Maritime (SHIP) | 2005-2009 | 5,713,949.28% |
NovaBay Pharmaceuticals (NBY) | 2005-2009 | 3,424,939.16% |
OPTIMIZERx (OPRX) | 2005-2009 | 2,804,900% |
India Globalization Capital (IGC) | 2005-2009 | 2,299,900% |
Taoping (TAOP) | 2005-2009 | 1,478,398.57% |
TherapeuticsMD (TXMD) | 2005-2009 | 652,510.44% |
Alaunos Therapeutics (TCRT) | 2005-2009 | 422,757.14% |
Perspective Therapeutics (CATX) | 2005-2009 | 296,566.67% |
Iveda Solutions (IVDA) | 2005-2009 | 265,714.7% |
Metalla Royalty & Streaming (MTA) | 2005-2009 | 151,014.29% |
Ring Energy (REI) | 2005-2009 | 133,233.33% |
Alto Ingredients (ALTO) | 2005-2009 | 130,460.42% |
ProMIS Neurosciences (PMN) | 2005-2009 | 77,002.8% |
Danaos (DAC) | 2005-2009 | 68,818.66% |
Lixte Biotechnology (LIXT) | 2005-2009 | 29,008.91% |
Astrana Health (ASTH) | 2005-2009 | 21,112.12% |
Champions Oncology (CSBR) | 2005-2009 | 20,369.08% |
Xcel Brands (XELB) | 2005-2009 | 20,350% |
TG Therapeutics (TGTX) | 2005-2009 | 19,989.29% |
Universal Insurance (UVE) | 2005-2009 | 19,208.72% |